Suppr超能文献

亚临床和显性甲状腺功能亢进症患者内皮功能及止血和炎症参数的变化。

The changes in the endothelial function and haemostatic and inflammatory parameters in subclinical and overt hyperthyroidism.

机构信息

Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Sklodowskiej-Curie 24A, 15-276 Białystok, Poland.

Department of Statistics and Medical Informatics, Medical University of Bialystok, Szpitalna 37, 15-295 Białystok, Poland.

出版信息

Int J Endocrinol. 2013;2013:981638. doi: 10.1155/2013/981638. Epub 2013 Dec 3.

Abstract

Introduction. The aim of the present study was to compare the levels of circulating markers of endothelial function and low-grade inflammation in patients with subclinical and overt hyperthyroidism (OH) due to Graves disease (GD) and toxic nodular goiter (TNG). Material and Methods. The group studied consisted of 42 patients with GD, 75 patients with TNG, and 39 healthy controls. Results. Circulating markers of endothelial dysfunction were elevated in the patients with both SH and OH, but the concentrations of interleukin-12 (IL-12) (P < 0.05), IL-18 (P < 0.05), fibrinogen (P < 0.01), and von Willebrand factor (vWF) (P < 0.05) were significantly higher in the OH than in the SH group. The highest levels of IL-6, IL-12, IL-18, vWF, sVCAM-1, and fibrinogen were found in the patients with GD, but the differences between the GD, and TNG groups were not significant. In the subjects with OH serum IL-6 was positively associated with FT3 (R = 0.276, P < 0.05), FT4 (R = 0.273, P < 0.05), and thyroid peroxidase antibodies (R = 0.346, P < 0.01) levels. Conclusion. Our results may suggest that both SH and OH may be associated with endothelial dysfunction, which is reflected by decreased fibrinolytic activity, hypercoagulability, and increased levels of IL-6, IL-12, and IL-18 and depends not only on the cause but also on the degree of hyperthyroidism.

摘要

简介。本研究的目的是比较亚临床和显性甲状腺功能亢进(OH)患者的循环内皮功能和低度炎症标志物水平,这些患者是由于 Graves 病(GD)和毒性结节性甲状腺肿(TNG)引起的。

材料与方法。研究组包括 42 例 GD 患者、75 例 TNG 患者和 39 例健康对照者。

结果。SH 和 OH 患者的循环内皮功能障碍标志物均升高,但 OH 患者的白细胞介素-12(IL-12)(P < 0.05)、白细胞介素-18(IL-18)(P < 0.05)、纤维蛋白原(P < 0.01)和血管性血友病因子(vWF)(P < 0.05)浓度明显高于 SH 组。IL-6、IL-12、IL-18、vWF、sVCAM-1 和纤维蛋白原的水平在 GD 患者中最高,但 GD 和 TNG 组之间无显著差异。在 OH 患者中,血清 IL-6 与 FT3(R = 0.276,P < 0.05)、FT4(R = 0.273,P < 0.05)和甲状腺过氧化物酶抗体(R = 0.346,P < 0.01)水平呈正相关。

结论。我们的结果可能表明,SH 和 OH 可能都与内皮功能障碍有关,这反映了纤溶活性降低、高凝状态和 IL-6、IL-12 和 IL-18 水平升高,这不仅取决于病因,还取决于甲状腺功能亢进的程度。

相似文献

2
Endothelial dysfunction in Graves' disease.格雷夫斯病中的血管内皮功能障碍。
Adv Med Sci. 2013;58(1):31-7. doi: 10.2478/v10039-012-0047-1.
9
Serum cytokines in thyrotoxicosis.甲状腺毒症中的血清细胞因子。
J Clin Endocrinol Metab. 1999 Feb;84(2):435-9. doi: 10.1210/jcem.84.2.5436.

引用本文的文献

3
Evaluation of hemostasis in hyperthyroid cats.评估甲状腺功能亢进症猫的止血功能。
J Vet Intern Med. 2021 Nov;35(6):2636-2645. doi: 10.1111/jvim.16274. Epub 2021 Sep 30.
7
Platelet function in cats with hyperthyroidism.猫甲状腺功能亢进症的血小板功能。
J Feline Med Surg. 2020 Dec;22(12):1214-1218. doi: 10.1177/1098612X20920585. Epub 2020 May 21.
9
Hypertension in Thyroid Disorders.甲状腺疾病中的高血压
Front Endocrinol (Lausanne). 2019 Jul 17;10:482. doi: 10.3389/fendo.2019.00482. eCollection 2019.

本文引用的文献

3
Thyroid disorders and hypercoagulability.甲状腺疾病与高凝状态。
Semin Thromb Hemost. 2011 Feb;37(1):17-26. doi: 10.1055/s-0030-1270067. Epub 2011 Jan 19.
8
Thyroid hormones and aging.甲状腺激素与衰老
Hormones (Athens). 2008 Jan-Mar;7(1):28-35. doi: 10.14310/horm.2002.1111035.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验